Cardiac β-Adrenoceptor Desensitization Due to Increased β-Adrenoceptor Kinase Activity in Chronic Uremia
暂无分享,去创建一个
K. Leineweber | O. Brodde | G. Abraham | K. Pönicke | I. Heinroth-Hoffmann | B. Osten | K. Pönicke | I. Heinroth‐Hoffmann
[1] K. Leineweber,et al. Chamber‐specific alterations of noradrenaline uptake (uptake1) in right ventricles of monocrotaline‐treated rats , 2000, British journal of pharmacology.
[2] A. Levin,et al. Cardiovascular disease in chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] S. Dhein,et al. Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats. , 2000, Journal of the American College of Cardiology.
[4] E. Ritz,et al. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. , 2000, Journal of the American Society of Nephrology : JASN.
[5] N. Hatori,et al. Myocardial morphology and cardiac function in rats with renal failure. , 2000, Japanese circulation journal.
[6] V. Campese,et al. Neurogenic factors and hypertension in renal disease. , 2000, Kidney international. Supplement.
[7] J L Benovic,et al. Regulation of G protein-coupled receptor kinases. , 2000, Trends in cardiovascular medicine.
[8] M. Michel,et al. Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.
[9] W. Koch,et al. Therapeutic potential of G-protein coupled receptor kinases in the heart. , 1999, Expert opinion on investigational drugs.
[10] J. Benovic,et al. G‐Protein–coupled receptor kinase expression in hypertension , 1999, Clinical pharmacology and therapeutics.
[11] D. Wheeler. Ischaemic heart disease after renal transplantation: how to assess and minimize the risk. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] P. Blankestijn,et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. , 1999, The New England journal of medicine.
[13] S. Ertürk. Long-term evolution of cardiomyopathy in dialysis patients. , 1999, Kidney international.
[14] R. Lefkowitz,et al. β-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy Regulation by β- but not α1-Adrenergic Stimulation , 1999 .
[15] R. Willette,et al. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. , 1999, Hypertension.
[16] A. Levey. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] R. Lefkowitz,et al. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.
[18] C. Wingo,et al. Hyperkalemia: a potential silent killer. , 1998, Journal of the American Society of Nephrology : JASN.
[19] W. Koch,et al. Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase* , 1997, The Journal of Biological Chemistry.
[20] J. Benovic,et al. G-protein-coupled receptor kinase activity is increased in hypertension. , 1997, The Journal of clinical investigation.
[21] V. Campese,et al. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. , 1997, Kidney international.
[22] M. Michel,et al. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[23] GertRichardt,et al. Upregulation of Cardiac Uptake1 Carrier in Ischemic and Nonischemic Rat Heart , 1996 .
[24] G. Richardt,et al. Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. , 1996, Circulation research.
[25] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[26] E. Ritz,et al. New insights into mechanisms of blood pressure regulation in patients with uraemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] M. Caron,et al. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. , 1995, The Journal of biological chemistry.
[28] E. Ritz,et al. Changes of vascular architecture independent of blood pressure in experimental uremia. , 1995, American journal of hypertension.
[29] M. Sallese,et al. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2. , 1995, The Journal of clinical investigation.
[30] M. Böhm,et al. Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.
[31] R. Bigazzi,et al. Altered norepinephrine turnover in the brain of rats with chronic renal failure. , 1994, Journal of the American Society of Nephrology : JASN.
[32] E. Ritz,et al. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis , 1993, Journal of hypertension.
[33] M. Böhm,et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.
[34] M. Lohse,et al. Altered Expression of, ‐Adrenergic Receptor Kinase and 1‐Adrenergic Receptors in the Failing Human Heart , 1993 .
[35] R. Converse,et al. Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.
[36] J. Port,et al. Myocardial Catecholamine and Neuropeptide Y Depletion in Failing Ventricles of Patients With Idiopathic Dilated Cardiomyopathy: Correlation With β‐Adrenergic Receptor Downregulation , 1992, Circulation.
[37] J. Benovic. Purification and characterization of beta-adrenergic receptor kinase. , 1987, Methods in enzymology.
[38] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[39] C. Benedict,et al. Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. , 1978, Clinical science and molecular medicine.
[40] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[41] J. Zingraff,et al. Congestive cardiomyopathy in uraemic patients on long term haemodialysis. , 1977, British medical journal.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] P. Nemes,et al. The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. , 1975, Analytical biochemistry.
[44] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.